- Home
- HNNA vs OKYO Comparison
HNNA vs OKYO Comparison
Compare HNNA & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- OKYO
- Stock Information
- Founded
- HNNA 1989
- OKYO 2007
- Country
- HNNA United States
- OKYO United Kingdom
- Employees
- HNNA N/A
- OKYO N/A
- Industry
- HNNA Investment Managers
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HNNA Finance
- OKYO Health Care
- Exchange
- HNNA Nasdaq
- OKYO Nasdaq
- Market Cap
- HNNA 87.1M
- OKYO 85.0M
- IPO Year
- HNNA N/A
- OKYO 2022
- Fundamental
- Price
- HNNA $11.54
- OKYO $2.13
- Analyst Decision
- HNNA
- OKYO Strong Buy
- Analyst Count
- HNNA 0
- OKYO 1
- Target Price
- HNNA N/A
- OKYO $7.00
- AVG Volume (30 Days)
- HNNA 9.1K
- OKYO 56.1K
- Earning Date
- HNNA 08-06-2025
- OKYO 07-18-2025
- Dividend Yield
- HNNA 4.63%
- OKYO N/A
- EPS Growth
- HNNA 56.56
- OKYO N/A
- EPS
- HNNA 1.25
- OKYO N/A
- Revenue
- HNNA $35,816,000.00
- OKYO N/A
- Revenue This Year
- HNNA N/A
- OKYO N/A
- Revenue Next Year
- HNNA N/A
- OKYO N/A
- P/E Ratio
- HNNA $9.38
- OKYO N/A
- Revenue Growth
- HNNA 32.04
- OKYO N/A
- 52 Week Low
- HNNA $8.43
- OKYO $0.90
- 52 Week High
- HNNA $13.88
- OKYO $3.35
- Technical
- Relative Strength Index (RSI)
- HNNA 45.74
- OKYO 36.03
- Support Level
- HNNA $11.36
- OKYO $2.07
- Resistance Level
- HNNA $12.30
- OKYO $2.39
- Average True Range (ATR)
- HNNA 0.58
- OKYO 0.14
- MACD
- HNNA -0.01
- OKYO -0.00
- Stochastic Oscillator
- HNNA 10.98
- OKYO 17.50
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.